The Asia-Pacific cardiac monitoring market is expected to register a CAGR of 6% during the forecast period of 2018–2023. Cardiac monitoring devices are used to monitor and diagnose various abnormalities or disorders of the heart and the overall cardiovascular system.
Rise in the Incidences of Cardiovascular Diseases
Cardiovascular diseases (CVD) in Asia-Pacific region accounts for more than half of those affected worldwide. The factors which lead to cardiovascular diseases are obesity, diabetes, lifestyle, and dietary habits. Australia and New Zealand are reported to have high rates of mortality due to CVD diseases. The Heart Foundation states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country in 2014. Cardiovascular disease kills one Australian every 12 minutes. The rate of diagnosis of cardiovascular diseases is increasing over time due to high incidence rate of cardiac diseases and the need to control mortality rate by early diagnosis, and treatment for CVD with the help of cardiac monitoring devices. Hence, rise in the incidence of cardiovascular diseases drives the market. The other factors, such as investments in R&D from key players in innovative devices, rising usage of portable devices, and the demand for home-based, point of care and remote monitoring cardiac systems are the major drivers for the market.
Risk of Infection from Implantable Monitoring Devices
Cardiac monitoring device is used by patients who require continuous monitoring of the heart for better treatment. Monitoring the cardiac output is a common practice in patients who undergo surgeries, as they will be under anesthesia and critical care. Cardiac implantable devices are used for related cardiac surgeries to monitor heart rate continuously. The patients who undergo any invasive procedures are at a risk of infection. The rising rate of infections due to these devices has tremendous economic implications on hospitals. Patients who are implanted with these monitoring devices are likely to require prolonged hospital stays, and the related costs rack up quickly. However, minimally invasive cardiac output monitors for clinical practice have been introduced into the market, which do not require the insertion of pacemaker. These devices utilize different techniques to monitor, and each has their own sources of potential errors and degree of invasiveness. Hence, the risk of infection due to implantable medical devices is a constraint for the market. The other factors, such as the low level of accuracy with invasive cardiac output monitoring devices and the stringent FDA and validator regulations are the major restraints for the Asia-Pacific cardiac monitoring market.
China Leads the Market in Asia-Pacific
China held the largest share in the cardiac monitoring market, in 2017 in the Asia-Pacific region due to high incidence of cardiac disease.
Key Developments in the Market
- September 2017: ABBOTT Confirm Insertable Cardiac Monitor (ICM) the world's first and only smartphone compatible ICM which got FDA clearance.
- July 2017: GE Healthcare collaborated with Heartflow technologies to provide better care of coronary artery patients.
The major players include Cardiac Science Corporation, GE Healthcare, Medtronic Plc, Mennen Medical, Phillips Healthcare, Siemens AG, Roche Diagnostics, Canon Medical Systems Corporation, and Welch Allyn, among others.
Reasons to Purchase the Report
- Current and future Asia-Pacific cardiac monitoring market outlook in the developed and emerging markets.
- Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
- The segment that is expected to dominate the market.
- Regions that are expected to witness the fastest growth during the forecast period.
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1.1 Rise in the Incidence of Cardiovascular Diseases
6.1.2 Investments in R&D from Key Players in Innovative Products
6.1.3 Rising Usage of Portable Devices
6.1.4 Demand for Home-based, Point of Care and Remote Patients Monitoring Cardiac Systems
6.2.1 Risk of Infection Due to Implantable Monitoring Devices
6.2.2 Low Level of Accuracy with Invasive Cardiac Output Monitoring Devices
6.2.3 Lack of Skilled Personnel for the Operation of the Devices
6.4 Key Challenges
7. Market Segmentation
7.1 By Device Type
7.1.1 Insertable Cardiac Monitoring Devices
7.1.2 Cardiac Output Monitoring Devices
7.1.4 Cardiac Event Monitoring Systems
7.2 By Geography
184.108.40.206 Australia & New Zealand
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Cardiac Science Corporation
9.2 GE Healthcare
9.3 Medtronic Plc
9.4 Mennen Medical
9.5 Phillips Healthcare
9.6 Roche Diagnostics
9.7 Siemens Healthcare
9.8 Canon Medical Systems Corporation
9.9 Welch Allyn
*List not Exhaustive
10. Future of the Market